LINC02736

Across TCGA pan-cancer cohorts, LINC02736 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC02736 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher LINC02736 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02736 expression acts as an unfavorable survival marker, although some lineages such as ESCA and SKCM show a favorable association.

CHOL, UVM, and LIHC are the cancer types where LINC02736 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.253	0.817	<.001	81	view →
UVM	OS	Tertile	All	0.354	0.852	<.001	76	view →
LIHC	OS	Tertile	All	0.476	0.730	<.001	69	view →
KIRC	DFS	Tertile	All	0.434	0.668	<.001	67	view →
BRCA	OS	Quartile	III,IV	0.753	0.855	.022	40	view →
THYM	DFS	Quartile	II,III,IV	0.433	0.827	.002	34	view →
UCEC	DFS	Tertile	All	0.762	0.870	<.001	32	view →
KICH	OS	Tertile	II,III,IV	0.369	0.939	<.001	29	view →
COAD	DFS	Tertile	II,III,IV	0.417	0.694	<.001	27	view →
ESCA	OS	Median	III,IV	0.681	0.434	.005	18	view →
SKCM	DFS	Tertile	All	0.280	0.189	.020	18	view →
BLCA	OS	Quartile	IV	0.325	0.500	.008	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC02736–CHOL (OS)

Open the CHOL breakdown →